Bioclinical Test to Predict Nephropathia Epidemica Severity at Hospital Admission

We conducted a multicenter, retrospective cohort study of hospitalized patients with serologically proven nephropathia epidemica (NE) living in Ardennes Department, France, during 2000–2014 to develop a bioclinical test predictive of severe disease. Among 205 patients, 45 (22.0%) had severe NE. We f...

Descripción completa

Detalles Bibliográficos
Autores principales: Hentzien, Maxime, Mestrallet, Stéphanie, Halin, Pascale, Pannet, Laure-Anne, Lebrun, Delphine, Dramé, Moustapha, Bani-Sadr, Firouzé, Galempoix, Jean-Marc, Strady, Christophe, Reynes, Jean-Marc, Penalba, Christian, Servettaz, Amélie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004848/
https://www.ncbi.nlm.nih.gov/pubmed/29774835
http://dx.doi.org/10.3201/eid2406.172160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004848/
https://www.ncbi.nlm.nih.gov/pubmed/29774835
http://dx.doi.org/10.3201/eid2406.172160

Ejemplares similares